Acasti Pharma reported $459K in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Addus HomeCare USD 16.83M 155K Dec/2025
Amarin USD 45.36M 8.64M Dec/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Option Care Health USD 639.83M 11.96M Dec/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Tilray USD 114.5M 3.69M Sep/2025